Stephen Basil Thomas, Director at Climb Bio, Inc. (CLYM), sold 200,000 shares at $5.23 ($1.1M) on 2026-02-12, disclosed to the SEC on 2026-02-17.
Open-market sale of $1.1M CLYM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.23 | 90,000 | $471K | 44.5% |
| 2 | $5.23 | 90,000 | $471K | 44.5% |
| 3 | $5.81 | 10,000 | $58K | 5.5% |
| 4 | $5.81 | 10,000 | $58K | 5.5% |
| Total | $5.29 avg | 200,000 | $1.1M | 100% |
| Filing → |